Neurogene Appoints Christy Shafer as Chief Commercial Officer and Christine Mikail, J.D., to Board of Directors [Yahoo! Finance]
Neurogene Appoints Christy Shafer as Chief Commercial Officer and Christine Mikail, J.D., to Board of Directors
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Neurogene (NGNE) had its price target lowered by Canaccord Genuity Group Inc. from $200.00 to $180.00. They now have a "buy" rating on the stock.
Neurogene Reports Full Year 2025 Financial Results and Highlights Recent Updates [Yahoo! Finance]